These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31125700)

  • 1. Laboratory markers as useful prognostic measures for survival in patients with spinal metastases.
    Schoenfeld AJ; Ferrone ML; Passias PG; Blucher JA; Barton LB; Shin JH; Harris MB; Schwab JH
    Spine J; 2020 Jan; 20(1):5-13. PubMed ID: 31125700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-operative management of spinal metastases: A prognostic model for failure.
    Schoenfeld AJ; Schwab JH; Ferrone ML; Blucher JA; Balboni TA; Barton LB; Chi JH; Kang JD; Losina E; Katz JN
    Clin Neurol Neurosurg; 2020 Jan; 188():105574. PubMed ID: 31707291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
    You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
    Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting survival in older patients treated for cervical spine fractures: development of a clinical survival score.
    Cronin PK; Ferrone ML; Marso CC; Stieler EK; Beck AW; Blucher JA; Makhni MC; Simpson AK; Harris MB; Schoenfeld AJ
    Spine J; 2019 Sep; 19(9):1490-1497. PubMed ID: 31125694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive ability of routinely collected laboratory markers for surgically treated spinal metastases: a retrospective single institution study.
    Li Z; Huang L; Guo B; Zhang P; Wang J; Wang X; Yao W
    BMC Cancer; 2022 Nov; 22(1):1231. PubMed ID: 36447178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of 30- and 90-Day Survival Following Surgical Intervention for Spinal Metastases: A Prognostic Study Conducted at Four Academic Centers.
    Schoenfeld AJ; Leonard DA; Saadat E; Bono CM; Harris MB; Ferrone ML
    Spine (Phila Pa 1976); 2016 Apr; 41(8):E503-9. PubMed ID: 27064339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS).
    Schoenfeld AJ; Le HV; Marjoua Y; Leonard DA; Belmont PJ; Bono CM; Harris MB
    Spine J; 2016 Apr; 16(4):482-90. PubMed ID: 26409416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of scoring systems and prognostic factors in patients with spinal metastases from nasopharyngeal carcinoma.
    Kumar N; Tan JJ; Zaw AS; Lim JL; Wai KL; Malhotra R; Loh TK; Liu GK; Thambiah J
    Spine J; 2014 Dec; 14(12):2946-53. PubMed ID: 24912121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse Association between Platelet-Lymphocyte Ratio and Prognosis in Terminally Ill Cancer Patients: A Preliminary Study.
    Lee Y; Kim YW; Park DK; Hwang IC
    J Palliat Med; 2017 May; 20(5):533-537. PubMed ID: 27858496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
    Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S
    J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Laboratory Markers and Ambulatory Function at Presentation for Post-Treatment Morbidity and Mortality Following Epidural Abscess.
    Goh BC; Ferrone ML; Barghi A; Liu CY; Cronin PK; Blucher JA; Makhni MC; Kang JD; Schoenfeld AJ
    Spine (Phila Pa 1976); 2020 Aug; 45(15):E959-E966. PubMed ID: 32675612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
    Bilen MA; Martini DJ; Liu Y; Lewis C; Collins HH; Shabto JM; Akce M; Kissick HT; Carthon BC; Shaib WL; Alese OB; Pillai RN; Steuer CE; Wu CS; Lawson DH; Kudchadkar RR; El-Rayes BF; Master VA; Ramalingam SS; Owonikoko TK; Harvey RD
    Cancer; 2019 Jan; 125(1):127-134. PubMed ID: 30329148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
    Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD
    Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases?
    Paulino Pereira NR; Beks RB; Janssen SJ; Harris MB; Hornicek FJ; Ferrone ML; Schwab JH
    Spine J; 2016 Aug; 16(8):951-61. PubMed ID: 27033311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
    Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
    J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling 1-year survival after surgery on the metastatic spine.
    Ghori AK; Leonard DA; Schoenfeld AJ; Saadat E; Scott N; Ferrone ML; Pearson AM; Harris MB
    Spine J; 2015 Nov; 15(11):2345-50. PubMed ID: 26160329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.